LENMELDY Trademark

Trademark Overview


On Monday, June 5, 2023, a trademark application was filed for LENMELDY with the United States Patent and Trademark Office. The USPTO has given the LENMELDY trademark a serial number of 98028058. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, December 3, 2024. This trademark is owned by Orchard Therapeutics (Europe) Limited. The LENMELDY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Medicinal preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders
lenmeldy

General Information


Serial Number98028058
Word MarkLENMELDY
Filing DateMonday, June 5, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Medicinal preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOrchard Therapeutics (Europe) Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon W68PW
GB

Party NameOrchard Therapeutics (Europe) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon W68PW
GB

Trademark Events


Event DateEvent Description
Sunday, July 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 26, 2024ASSIGNED TO EXAMINER
Thursday, June 8, 2023NEW APPLICATION ENTERED
Monday, February 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU EXTENSION 1 FILED
Tuesday, December 3, 2024SOU EXTENSION 1 GRANTED